Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .


These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name YouTube
Purpose Show YouTube content
Name Twitter
Purpose activate Twitter Feeds

Transfer Tandem

Development of targeted immunmodulatory strategies by means of AI-based robotics platforms

Pandemic preparedness needs novel widely available solutions, which requires transfer of knowledge and technology to industry. The CoViPa consortium aims to pave the way for a prototype that adopts and combines knowledge on immune mechanisms with robotics technologies to accelerate the development of diagnostics, therapeutics, and vaccines for pandemic pathogens.
The Transfer Group develops robotic platforms for lab automation and their application to autonomous high-throughput formats. The platforms are used to assist in COVID-19 biomarker assay and antibody analyses.
These technologies are of high relevance for the ongoing pandemic and, given their versatility, increase pandemic preparedness.

Kathrin de la Rosa 

Daniel Leidner 

to top
powered by webEdition CMS